Were you looking for information about Mycophenolate? Mycophenlate is a common misspelling of mycophenolate.
Mycophenolate (CellCept®, Myfortic®) is a prescription medication approved for use with other drugs to prevent organ rejection in people who have received a kidney, heart, or liver transplant. It comes in the form of a delayed-release tablet, a regular tablet, a capsule, an oral liquid solution, and an intravenous (IV) injection. The tablets, capsules, and liquid solution are usually taken by mouth twice a day. The injection is given as an infusion into a vein twice a day.
(For information on side effects, generic availability, and what to discuss with your healthcare provider, click Mycophenolate. You can also click any of the links in the box to the right for specific information.)
HealthSavvy Sign In
|